Patents

This referral, identified as G1/25, could have wide-reaching implications and will hopefully provide some clarity on the extent of required...

Register for this 45 minute webinar on 11th September 2025.

The Enlarged Board of Appeal of the European Patent Office has recently delivered the long-awaited decision in case G...

As Europe seeks to transform cutting-edge innovation into commercial success, recent developments from both the EPO and the IPO...

This case draws attention to the importance of clearly highlighting an invention’s technical character in a patent application.

We highlight the key findings from the EPO's Patent Index 2024 report.

This month an update to Japanese patent practice took effect.

What challenges are pharmaceutical companies facing when attempting to patent AI-assisted drugs?

What is the current environment relating to patent oppositions at the EPO?